학술논문

Phase I trial (VEG108925) of cetuximab, irinotecan, and pazopanib (GW786034) administered concurrently.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2010, 28 15, 1p. Supplement: S
Subject
Language
English
ISSN
15277755